GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹37 Cr | ₹36 Cr | ₹36 Cr | ₹32 Cr | ₹26 Cr |
What is the latest Total Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹36 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹26 Cr |
How is Total Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 2.93 | |
| Mar2024 | ₹36 Cr | 1.39 | |
| Mar2023 | ₹36 Cr | 12.71 | |
| Mar2022 | ₹32 Cr | 22.45 | |
| Mar2021 | ₹26 Cr | - | |
Compare Total Current Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,414.4 Cr | -6.9% | -15.7% | 10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -6.9% |
-15.7% |
10.9% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses